These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7184998)

  • 81. Suicide with dapsone.
    Singhal SK
    Indian J Lepr; 1988 Jan; 60(1):87-9. PubMed ID: 3204280
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Acute dapsone poisoning in a child.
    Saxena KM; Pathak AK
    Indian J Pediatr; 1967 Oct; 34(237):367-71. PubMed ID: 5594834
    [No Abstract]   [Full Text] [Related]  

  • 83. Factors influencing the clinical efficacy of activated charcoal.
    Watson WA
    Drug Intell Clin Pharm; 1987 Feb; 21(2):160-6. PubMed ID: 3549212
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Charcoal stercolith with intestinal perforation in a patient treated for amitriptyline ingestion.
    Gomez HF; Brent JA; Munoz DC; Mimmack RF; Ritvo J; Phillips S; McKinney P
    J Emerg Med; 1994; 12(1):57-60. PubMed ID: 8163807
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Effect of oral activated charcoal on quinine elimination.
    Lockey D; Bateman DN
    Br J Clin Pharmacol; 1989 Jan; 27(1):92-4. PubMed ID: 2706191
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Accidental dapsone poisoning in children.
    Gomber S; Singh RP; Chawla R; Gupta R; Sharma S
    Indian Pediatr; 1994 Sep; 31(9):1123-5. PubMed ID: 7883376
    [No Abstract]   [Full Text] [Related]  

  • 87. Carbamazepine overdose--the effects of multiple dose activated charcoal.
    Wason S; Baker RC; Carolan P; Seigel R; Druckenbrod RW
    J Toxicol Clin Toxicol; 1992; 30(1):39-48. PubMed ID: 1542148
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Reduction of absorption of digoxin, phenytoin and aspirin by activated charcoal in man.
    Neuvonen PJ; Elfving SM; Elonen E
    Eur J Clin Pharmacol; 1978 May; 13(3):213-8. PubMed ID: 668776
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Effect of activated charcoal in reducing paracetamol absorption at a supra-therapeutic dose.
    Wananukul W; Klaikleun S; Sriapha C; Tongpoo A
    J Med Assoc Thai; 2010 Oct; 93(10):1145-9. PubMed ID: 20973316
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Effect of activated charcoal on absorption of nortriptyline.
    Crome P; Dawling S; Braithwaite RA; Masters J; Walkey R
    Lancet; 1977 Dec; 2(8050):1203-5. PubMed ID: 73903
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Effect of activated charcoal on absorption of tolbutamide and valproate in man.
    Neuvonen PJ; Kannisto H; Hirvisalo EL
    Eur J Clin Pharmacol; 1983; 24(2):243-6. PubMed ID: 6404636
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Dapsone poisoning.
    McLeod-Kennedy L; Leach M
    Blood; 2019 Jun; 133(23):2551. PubMed ID: 31171542
    [No Abstract]   [Full Text] [Related]  

  • 93. Strawberry-flavoured activated charcoal.
    Oppenheim RC
    Med J Aust; 1980 Jan; 1(1):39. PubMed ID: 7360079
    [No Abstract]   [Full Text] [Related]  

  • 94. Investigation and management of the poisoned patient.
    Coulson JM; Thompson JP
    Clin Med (Lond); 2008 Feb; 8(1):89-91. PubMed ID: 18335679
    [No Abstract]   [Full Text] [Related]  

  • 95. Utilizing high-resolution imaging to objectively assess activated charcoal's effects on facial skin.
    Brody G; Yale K; Michelle L; Haller CN; Mesinkovska NA
    J Cosmet Dermatol; 2022 Apr; 21(4):1778-1780. PubMed ID: 34766700
    [No Abstract]   [Full Text] [Related]  

  • 96. Correction to: Novel method to estimate the appropriate dosing interval for activated charcoal to avoid interaction with other drugs.
    Ohtani H; Nakamura K; Imaoka A; Akiyoshi T
    Eur J Clin Pharmacol; 2020 Nov; 76(11):1537. PubMed ID: 32936338
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Activated charcoal--past, present and future.
    Derlet RW; Albertson TE
    West J Med; 1986 Oct; 145(4):493-6. PubMed ID: 3538661
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Clinical features and management of poisoning due to antimalarial drugs.
    Jaeger A; Sauder P; Kopferschmitt J; Flesch F
    Med Toxicol Adverse Drug Exp; 1987; 2(4):242-73. PubMed ID: 3306266
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Oral activated charcoal in the treatment of intoxications. Role of single and repeated doses.
    Neuvonen PJ; Olkkola KT
    Med Toxicol Adverse Drug Exp; 1988; 3(1):33-58. PubMed ID: 3285126
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Management of dapsone poisoning complicated by methaemoglobinaemia.
    Dawson AH; Whyte IM
    Med Toxicol Adverse Drug Exp; 1989; 4(5):387-92. PubMed ID: 2811676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.